Advanced Glycation End Products' Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Jun YangMingqiang LinMengyan ZhangZhiping WangHancui LinYilin YuQunhao ZhengXiaohui ChenYahua WuQiwei YaoJiancheng LiPublished in: Genetics research (2023)
AGER may be a candidate for the prognostic biomarker of LUAD and LUSC related to tumor immune microenvironment.